BRPI0911451A2 - egfr / her / erb biomarkers for drug efficacy - Google Patents

egfr / her / erb biomarkers for drug efficacy

Info

Publication number
BRPI0911451A2
BRPI0911451A2 BRPI0911451A BRPI0911451A BRPI0911451A2 BR PI0911451 A2 BRPI0911451 A2 BR PI0911451A2 BR PI0911451 A BRPI0911451 A BR PI0911451A BR PI0911451 A BRPI0911451 A BR PI0911451A BR PI0911451 A2 BRPI0911451 A2 BR PI0911451A2
Authority
BR
Brazil
Prior art keywords
erb
biomarkers
egfr
drug efficacy
efficacy
Prior art date
Application number
BRPI0911451A
Other languages
Portuguese (pt)
Inventor
W Grunt Thomas
Shabbir Waheed
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of BRPI0911451A2 publication Critical patent/BRPI0911451A2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/485—Epidermal growth factor [EGF] (urogastrone)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
BRPI0911451A 2008-05-25 2009-05-21 egfr / her / erb biomarkers for drug efficacy BRPI0911451A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5601608P 2008-05-25 2008-05-25
PCT/US2009/044771 WO2009151908A1 (en) 2008-05-25 2009-05-21 Biomarkers for egfr/her/erbb drug efficacy

Publications (1)

Publication Number Publication Date
BRPI0911451A2 true BRPI0911451A2 (en) 2019-09-24

Family

ID=41078344

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911451A BRPI0911451A2 (en) 2008-05-25 2009-05-21 egfr / her / erb biomarkers for drug efficacy

Country Status (4)

Country Link
AU (1) AU2009257802A1 (en)
BR (1) BRPI0911451A2 (en)
CA (1) CA2722890A1 (en)
WO (1) WO2009151908A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338456B2 (en) * 2010-01-13 2012-12-25 Wyeth Llc Cut-point in PTEN protein expression that accurately identifies tumors and is predictive of drug response to a pan-ErbB inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR056857A1 (en) * 2005-12-30 2007-10-24 U3 Pharma Ag DIRECTED ANTIBODIES TO HER-3 (RECEIVER OF THE HUMAN EPIDERMAL GROWTH FACTOR-3) AND ITS USES
EP1996193A2 (en) * 2006-03-13 2008-12-03 OSI Pharmaceuticals, Inc. Combined treatment with an egfr kinase inhibitor and an agent that sensitizes tumor cells to the effects of egfr kinase inhibitors
WO2008019375A2 (en) * 2006-08-07 2008-02-14 The Board Of Regents Of The University Of Texas System Proteomic patterns of cancer prognostic and predictive signatures

Also Published As

Publication number Publication date
WO2009151908A1 (en) 2009-12-17
CA2722890A1 (en) 2009-12-17
AU2009257802A1 (en) 2009-12-17

Similar Documents

Publication Publication Date Title
BRPI0920521A2 (en) pharmaceutical combination
BRPI0919548A2 (en) insert package
BRPI0912271A2 (en) structured co-authorship
DK2310071T3 (en) ECGOGEN MEDICAL CHANNEL
BRPI0907376A2 (en) Photobiorretador
BRPI0914649A2 (en) Piprazole-quinazolines
DK2837348T3 (en) CRYO-SURGICAL PROCEDURES
DK2300238T3 (en) Ghost-safety feature
DK2310613T3 (en) IMPROVED BROADLINE FOR RISK
BRPI0922884A2 (en) cancer treatment compounds
BRPI0909287A2 (en) Retention
BRPI0907522A2 (en) biarlamides
DK2271618T3 (en) Pharmaceutical compounds
BRPI0907863A2 (en) pyrrolopyrimidinecarboxamides
BRPI0909634A2 (en) 2-aminoquinolines
DE112009000183A5 (en) Sicherheitsvorreiber
FI20085425A0 (en) Sulfaattiesihydrolyysikeittomenetelmä
BRPI0909637A2 (en) 2-aminoquinolines
AT507449A3 (en) DÄMMSTOFFBEFESTIGER
BRPI0917718A2 (en) shoe
BRPI0916990A2 (en) Insecticide Combinations
BRPI0913872A2 (en) multi bandage
BRPI0918508A2 (en) ortho-aminoanilides for cancer treatment
BRPI0919750A2 (en) streaming
ITBS20080009A1 (en) LAMP

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.